Skip to main content
. 2018 May 18;8(32):18180–18196. doi: 10.1039/c7ra12568b

Fig. 12. Effect of wedelolactone and glibenclamide on the atherogenic and coronary risk index of the streptozotocin (STZ)-induced type II diabetic mellitus rats. (a) atherogenic index and (b) coronary risk index. The comparisons were made by ANOVA followed by Dunnett's test. cP < 0.05 is considered significant, bP < 0.01 is considered very significant, aP < 0.001 is considered extremely significant.

Fig. 12